Ticagrelor is: (A) Cyclooxygenase inhibitors, (B) Phosphodiesterase inhibitors, (C) Glycoprotein IIB/IIIA inhibitors, (D) P2Y12 receptor blocker
Answer is D. Ticagrelor is a novel, potent, reversible platelet P2Y12 inhibitor. It is shown to reduce the risk of cardiovascular death, MI, or stroke compared with clopidogrel in ACS patients.This agent reduced moality but increased the risk of bleeding.Other platelets P2Y12 receptor blocker are clopidogrel, prasugrel.Ref: Harrison 19e pg: 1596